Fennec Pharmaceuticals (FENC) Current Assets (2017 - 2025)

Fennec Pharmaceuticals (FENC) has 9 years of Current Assets data on file, last reported at $67.0 million in Q4 2025.

• For the quarter ending Q4 2025, Current Assets rose 51.94% year-over-year to $67.0 million; the trailing twelve-month figure through Dec 2025 stood at $67.0 million (up 51.94% YoY), and the FY2025 full-year result was $67.0 million, up 51.94% from the prior year.
• Current Assets for Q4 2025 stood at $67.0 million, up from $46.1 million in the prior quarter.
• Across five years, Current Assets topped out at $68.2 million in Q1 2024 and bottomed at $15.6 million in Q2 2022.
• The 5-year median for Current Assets is $27.9 million (2021), against an average of $35.6 million.
• The widest annual swing landed in 2022, when Current Assets tumbled 44.6%; it then jumped 221.62% in 2024.
• A 5-year view of Current Assets shows it stood at $22.4 million in 2021, then gained by 19.39% to $26.7 million in 2022, then rose by 0.49% to $26.9 million in 2023, then soared by 64.29% to $44.1 million in 2024, then jumped by 51.94% to $67.0 million in 2025.
• The last three Current Assets figures came in at $67.0 million (Q4 2025), $46.1 million (Q3 2025), and $40.8 million (Q2 2025), per Business Quant data.

Peer Comparison